InsidersTradesSigma
Track the HLB제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, HLB제약 has logged 58 insider filings. Market capitalisation: €272.9bn. The latest transaction was filed on 4 June 2026 (Other). Among the most active insiders: HLB생명과학. Every trade is accessible without an account.
58
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
1 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,787 of 29,062 companies
34.6
score / 100
Value28
Quality41
FCF yld-2.4%
Earn yld1.6%
EV/EBITDA30.4x
ROE-40%
Gross mgn52%
Net mgn2.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 4 June 2026
Declarations58 total
25 of 58 declarations
Acerca de HLB제약
HLB제약 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo y comercialización de productos farmacéuticos.